BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2001
View Archived Issues
Sepracor makes progress in first quarter of 2001
Read More
New HspE7 data confirm earlier findings in anal dysplasia
Read More
Positive preclinical and phase I results reported for BioSante's CAP
Read More
Lorus Therapeutics provides Q3 update
Read More
HIV protease inhibitor from Vertex/GSK commences third pivotal clinical trial
Read More
Cyclic amide-containing HNE inhibitors with good water solubility and in vivo potency
Read More
Collaborative Novartis/Schering effort yields novel antiangiogenic phthalazine
Read More
4-Oxohydroquinolines as selective, broad-spectrum antiherpesvirus agents
Read More
GW-2286, an orally active, selective VEGF RTK inhibitor
Read More
Novel cell cycle inhibitor Ro-41-4439 inhibits tumor growth in animal model
Read More
Abbott presents new antiinfluenza candidate at two April meetings
Read More
Potential of LTbetaR-Ig for colitis Rx discussed at Tokyo meeting
Read More
Lumigan introduced following mid-March approval by FDA
Read More
Cell Therapeutics prepares to advance PG-TXL to phase II
Read More
HE-2200 improves immune response to vaccination in preclinical study
Read More
LMW glycosaminoglycans show promise for preventing AD-associated neuropathology
Read More
PH-10 plus green light shows promise in pilot psoriasis study
Read More
Japanese study provides further support for use of DHA as AD prophylactic
Read More
Zeffix may represent a major advance for children with chronic HBV, according to EASL presentation
Read More
InSite Vision researchers prepare ophthalmic compositions of oxazolidinones
Read More
Dual PDE4 and TNF production inhibitors described by Pfizer
Read More
Cytostatic agent-integrin receptor antagonist conjugates with tumor-specific activity
Read More
Growth hormone secretagogues described by Merck for GH deficiency, osteoporosis
Read More
Merck KGaA presents new PDE5 inhibitors and their uses
Read More
New Merck compounds may have potential in the treatment of anxiety, convulsions
Read More
1,2,3-Thiadiazole COX-2 inhibitors designed at Merck Frosst
Read More
Ocular medications from Alcon with improved profile compared to PGF2alpha
Read More
